logo-loader

Akebia Therapeutics Inc

Receive alerts
Market:
NASDAQ
Market Cap:
$755.29 m
Price
6.35 USD
Change
1.11%
52 weeks high
9.30
52 weeks low
2.99

In brief

Based in Cambridge, Massachusetts, Akebia Therapeutics Inc. works to discover and develop therapeutic solutions leveraging the potential of hypoxia inducible factor (HIF) biology.